Donor-specific anti-HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation

Author(s):
Dulk, A.C. den; Shi, X.L.; Verhoeven, C.J.; Dubbeld, J.; Claas, F.H.J. (0000-0003-4157-6201); Wolterbeek, R.; Brand-Schaaf, S.H.; Verspaget, H.W. (0000-0001-5769-6887); Sarasqueta, A.F.; Laan, L.J.W. van der; Metselaar, H.J.; Hoek, B. van (0000-0001-6527-764X); Kwekkeboom, J.; Roelen, D.L.
Published
2018
Publication type
Article / Letter to editor
biliary stricturescomplicationsdonor-specific antibodiesHLA-antibody post-transplantationliver transplantationoutcome
Date issued
2018-02-28
Language
English
Is part of
Clinical Transplantation (2018), No. 2
hdl
1887/86246
doi
10.1111/ctr.13163